Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Alrosa sells stake in Angola's Catoca

11/29/24 ALRS

Sistema earned ₽1.8 billion in 9 months of 2024

11/29/24 AFKS

Rosseti Ural's net profit for the first 9 months of 2024 increased by almost 5%

11/28/24 MRKU

Shareholders of Whoosh approved dividends for 9 months 2024

11/28/24 WUSH

The Moscow Exchange transfers securities from the high-risk sector to the main trading mode

11/28/24 MOEX

VseInstrumentyru's net profit for 9 months of 2024 decreased by 95%

11/28/24 VSEH

Etalon to build 8 residential districts in Rostov-on-Don

11/28/24 ETLN

Moscow Exchange to resume morning trading on the derivatives market

11/28/24 MOEX

Svetofor driving school reported for 9 months of 2024 by RAS

11/27/24 SVET

Net profit of Rosseti Severo-Zapad for 9 months of 2024 increased by almost 70%

11/27/24 MRKZ